NO20030985D0 - Behandling av betennelsestilstander - Google Patents

Behandling av betennelsestilstander

Info

Publication number: NO20030985D0
Authority: NO; Norway
Prior art keywords: treatment; inflammatory conditions; inflammatory; mefloquine; administration
Prior art date: 2000-09-05

Application number

NO20030985A

Other languages

English (en)

Other versions

NO20030985L (no

NO323227B1 (no

Inventor

Benjamin Mark Skead

Robin Mark Bannister

Alan Rothaul

Original Assignee

Arakis Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-05

Filing date

2003-03-03

Publication date

2003-03-03

2003-03-03 Application filed by Arakis Ltd filed Critical Arakis Ltd

2003-03-03 Publication of NO20030985L publication Critical patent/NO20030985L/no

2003-03-03 Publication of NO20030985D0 publication Critical patent/NO20030985D0/no

2007-02-05 Publication of NO323227B1 publication Critical patent/NO323227B1/no

Links

230000004968 inflammatory condition Effects 0.000 title 1
XEEQGYMUWCZPDN-DOMZBBRYSA-N (-)-(11S,2'R)-erythro-mefloquine Chemical compound C([C@@H]1[C@@H](O)C=2C3=CC=CC(=C3N=C(C=2)C(F)(F)F)C(F)(F)F)CCCN1 XEEQGYMUWCZPDN-DOMZBBRYSA-N 0.000 abstract 1
208000023275 Autoimmune disease Diseases 0.000 abstract 1
208000027866 inflammatory disease Diseases 0.000 abstract 1
229960001962 mefloquine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Plant Substances (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Saccharide Compounds (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

NO20030985A 2000-09-05 2003-03-03 Anvendelse av (+)-erytro-mefloquin for fremstilling av et medikament NO323227B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0021776.0A GB0021776D0 (en)	2000-09-05	2000-09-05	The treatment of inflammatory disorders
PCT/GB2001/003924 WO2002019994A2 (en)	2000-09-05	2001-08-31	The treatment of inflammatory disorders

Publications (3)

Publication Number	Publication Date
NO20030985L NO20030985L (no)	2003-03-03
NO20030985D0 true NO20030985D0 (no)	2003-03-03
NO323227B1 NO323227B1 (no)	2007-02-05

Family

ID=9898880

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030985A NO323227B1 (no)	2000-09-05	2003-03-03	Anvendelse av (+)-erytro-mefloquin for fremstilling av et medikament

Country Status (22)

Country	Link
US (2)	US7034028B2 (no)
EP (1)	EP1315496B1 (no)
JP (1)	JP2004508323A (no)
CN (1)	CN1309388C (no)
AT (1)	ATE302008T1 (no)
AU (2)	AU2001284234B2 (no)
BR (1)	BR0113646A (no)
CA (1)	CA2419601A1 (no)
DE (1)	DE60112768T2 (no)
DK (1)	DK1315496T3 (no)
ES (1)	ES2245372T3 (no)
GB (1)	GB0021776D0 (no)
HK (1)	HK1054324A1 (no)
HU (1)	HUP0300934A2 (no)
IL (1)	IL154419A0 (no)
MX (1)	MXPA03001920A (no)
NO (1)	NO323227B1 (no)
NZ (1)	NZ524099A (no)
PL (1)	PL364030A1 (no)
PT (1)	PT1315496E (no)
WO (1)	WO2002019994A2 (no)
ZA (1)	ZA200301139B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0021776D0 (en) *	2000-09-05	2000-10-18	Arakis Ltd	The treatment of inflammatory disorders
GB0406014D0 (en) *	2004-03-17	2004-04-21	Arakis Ltd	Pharmaceutical composition and use
WO2006108666A1 (en) *	2005-04-13	2006-10-19	Proteosys Ag	Mefloquine, nelfinavir and saquinavir as novel agents for neurodegenerative and (neuro-) inflammatory diseases
JP2010513469A (ja) *	2006-12-20	2010-04-30	メドウェルラボラトリーズリミテッド	ポリ不飽和脂肪酸とアミンの新規なコンジュゲート、およびその治療的使用
EP2590641A2 (en) *	2010-07-07	2013-05-15	Polymedix, Inc.	Methods of immune modulation
CN113578299B (zh) *	2020-04-30	2023-11-10	中国石油化工股份有限公司	一种硅铝锆复合氧化物、催化裂化催化剂及其制备方法和应用
CN114452289B (zh) *	2020-12-31	2023-06-09	兰州大学	喹啉类衍生物在制备预防和/或治疗胃肠道疾病药物中的应用
CN114796216A (zh) *	2022-01-04	2022-07-29	南京医科大学	甲氟喹在防治全身代谢性炎症疾病中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU633499B2 (en) *	1988-06-30	1993-02-04	Michael H. Davis	Method of inhibiting the activity of human immunodeficiency virus (hiv) in vivo
CZ285937B6 (cs) *	1992-01-16	1999-12-15	Hoechst Aktiengesellschaft	Arylcykloalkylové deriváty, způsob přípravy těchto derivátů a jejich použití
WO1995024398A1 (en) *	1994-03-09	1995-09-14	Pfizer Inc.	Isoxazoline compounds as inhibitors of tnf release
JP4380800B2 (ja)	1997-03-07	2009-12-09	バーナリスリサーチリミテッド	マラリアの処置のための（＋）メフロキンの使用
WO1999026627A1 (en) *	1997-11-26	1999-06-03	Cerebrus Limited	(-)-mefloquine to block purinergic receptors and to treat movement or neurodegenerative disorders
EP1175216A2 (en) *	1999-04-30	2002-01-30	APT Pharmaceutical, L.L.C.	Antimalarian agents for the treatment of asthma
GB0021776D0 (en) *	2000-09-05	2000-10-18	Arakis Ltd	The treatment of inflammatory disorders

2000
- 2000-09-05 GB GBGB0021776.0A patent/GB0021776D0/en not_active Ceased
2001
- 2001-08-31 WO PCT/GB2001/003924 patent/WO2002019994A2/en active IP Right Grant
- 2001-08-31 DK DK01963202T patent/DK1315496T3/da active
- 2001-08-31 CA CA002419601A patent/CA2419601A1/en not_active Abandoned
- 2001-08-31 AU AU2001284234A patent/AU2001284234B2/en not_active Ceased
- 2001-08-31 BR BR0113646-1A patent/BR0113646A/pt not_active IP Right Cessation
- 2001-08-31 HU HU0300934A patent/HUP0300934A2/hu unknown
- 2001-08-31 NZ NZ524099A patent/NZ524099A/en unknown
- 2001-08-31 PT PT01963202T patent/PT1315496E/pt unknown
- 2001-08-31 ES ES01963202T patent/ES2245372T3/es not_active Expired - Lifetime
- 2001-08-31 PL PL01364030A patent/PL364030A1/xx not_active Application Discontinuation
- 2001-08-31 MX MXPA03001920A patent/MXPA03001920A/es active IP Right Grant
- 2001-08-31 AU AU8423401A patent/AU8423401A/xx active Pending
- 2001-08-31 DE DE60112768T patent/DE60112768T2/de not_active Expired - Fee Related
- 2001-08-31 EP EP01963202A patent/EP1315496B1/en not_active Expired - Lifetime
- 2001-08-31 IL IL15441901A patent/IL154419A0/xx unknown
- 2001-08-31 US US10/362,784 patent/US7034028B2/en not_active Expired - Fee Related
- 2001-08-31 AT AT01963202T patent/ATE302008T1/de not_active IP Right Cessation
- 2001-08-31 JP JP2002524479A patent/JP2004508323A/ja active Pending
- 2001-08-31 CN CNB018152023A patent/CN1309388C/zh not_active Expired - Fee Related
2003
- 2003-02-11 ZA ZA200301139A patent/ZA200301139B/en unknown
- 2003-03-03 NO NO20030985A patent/NO323227B1/no unknown
- 2003-09-03 HK HK03106286A patent/HK1054324A1/xx not_active IP Right Cessation
2005
- 2005-11-30 US US11/290,944 patent/US20060074106A1/en not_active Abandoned

Also Published As

Publication number	Publication date
PL364030A1 (en)	2004-12-13
AU8423401A (en)	2002-03-22
NZ524099A (en)	2004-04-30
GB0021776D0 (en)	2000-10-18
HUP0300934A2 (hu)	2003-11-28
ATE302008T1 (de)	2005-09-15
WO2002019994A2 (en)	2002-03-14
EP1315496B1 (en)	2005-08-17
DK1315496T3 (da)	2005-11-14
EP1315496A2 (en)	2003-06-04
CN1309388C (zh)	2007-04-11
CA2419601A1 (en)	2002-03-14
DE60112768T2 (de)	2006-02-02
MXPA03001920A (es)	2004-02-12
WO2002019994A3 (en)	2002-05-16
NO20030985L (no)	2003-03-03
JP2004508323A (ja)	2004-03-18
NO323227B1 (no)	2007-02-05
US20040029916A1 (en)	2004-02-12
IL154419A0 (en)	2003-09-17
US20060074106A1 (en)	2006-04-06
ZA200301139B (en)	2004-03-29
HK1054324A1 (en)	2003-11-28
DE60112768D1 (de)	2005-09-22
CN1452488A (zh)	2003-10-29
BR0113646A (pt)	2004-01-06
ES2245372T3 (es)	2006-01-01
AU2001284234B2 (en)	2004-11-04
US7034028B2 (en)	2006-04-25
PT1315496E (pt)	2005-11-30

Publication	Publication Date	Title
ATE340171T1 (de)	2006-10-15	Piperazinderivate zur behandlung bakterieller infektionen
NO20041882L (no)	2004-05-07	Fremgangsmater for behandling av okulare neovaskulaere sykdommer.
PT966447E (pt)	2003-07-31	Moleculas pequenas uteis no tratamento de doencas inflamatorias
PT1147114E (pt)	2003-10-31	Novos aralquilaminas de espirofuropiridinas uteis em terapia.
DE60023043D1 (de)	2006-02-16	(S,S)-Reboxetin zur Behandlung von Inkontinenz
MXPA03002814A (es)	2003-10-14	Derivados de morfolin-acetamida para el tratamiento de enfermedades inflamatorias.
MX238203B (es)	2006-06-28	Tratamiento de semillas con combinaciones de piretrinas, piretroides y tlametoxam.
DE60139466D1 (de)	2009-09-17	Behandlung von diabetes
NO20030985L (no)	2003-03-03	Behandling av betennelsestilstander
DK1305037T3 (da)	2007-09-17	Smertestillende medikament
BR0112264B1 (pt)	2012-05-15	dispositivo de tratamento de sangue.
IS7868A (is)	2005-05-26	Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum.
BR0115882A (pt)	2003-12-02	Emprego de compostos de 1-fenil-3-dimetilaminopropano no tratamento da incontinência urinária
TR200200278T2 (tr)	2002-06-21	Kalsilitik bileşimler
TR200103125T2 (tr)	2002-04-22	Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri.
IT1318619B1 (it)	2003-08-27	Procedimento e dispositivo di trattamento elettrochimico.
MA25852A1 (fr)	2003-07-01	Methode pour le traitement de l'inflammation.
PT1212119E (pt)	2004-07-30	Utilizacao de ciamemazina no tratamento do desmame subito de benzodiazepinas
NO20005548D0 (no)	2000-11-03	Mykobakterieinhibitorer
EP1409041A4 (en)	2007-05-16	HEMOFILTRATION SYSTEMS, METHODS AND DEVICES FOR THE TREATMENT OF DISEASES RELATED TO INFLAMMATION MEDIATORS
ATE343387T1 (de)	2006-11-15	S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen.
TR200003084T2 (tr)	2001-02-21	Paroxetine askorbat
IT1319665B1 (it)	2003-10-23	Addotti di corticosteroidi con polimeri polisaccaridici naturali.
UA40336A (uk)	2001-07-16	Спосіб хірургічного лікування екстрапірамідних гіперкінезів у хворих із церебросудинною патологією
IT1310431B1 (it)	2002-02-13	Metodo per il trattamento del terreno.